Clinical Trial Detail

NCT ID NCT04041310
Title Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nouscom SRL
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

colorectal cancer

Therapies

GAd-209-FSP + MVA-209-FSP

Age Groups: adult senior

No variant requirements are available.